Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Proton Pump Inhibitors. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced one-pot synthesis of Lansoprazole via patent CN112707889A. Achieves >99.9% purity and >92% yield with reduced waste, offering a reliable lansoprazole intermediate supplier solution.
Patent CN108623564B reveals a high-yield vanadium-catalyzed route for Dextro-Rabeprazole. Discover cost-effective manufacturing and superior enantioselectivity for your supply chain.
Patent CN102977076A reveals a high-purity R-lansoprazole synthesis using chiral titanium catalysis. Discover cost-effective manufacturing insights for pharmaceutical supply chains.
Novel one-pot method for esomeprazole magnesium reduces steps and enhances purity. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Patent CN112661744B reveals an isothermal purification method for Esomeprazole Sodium, achieving >99.5% purity with minimal R-enantiomer. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN108690836B details a mutated cyclohexanone monooxygenase for high-conversion esomeprazole synthesis, offering superior purity and scalability for API manufacturers.
Solve high-cost, low-yield issues in tegrazan intermediate production. New route achieves ≥99% purity with simplified steps and 100kgs+ scale capability.
Struggling with low yields in loflupridine hydrochloride synthesis? Discover emerging green chemistry routes for high-purity API production. Find reliable suppliers now.